Pen Needles Market to Hit USD 3.08 Billion by 2030 with 9.2% CAGR | MarketsandMarkets™
The pen needles market valued at US$ 1.69 Billion in 2023, is forecasted to grow at a robust CAGR of 9.2%, reaching US$ 1.81 ...
Hosted on MSN2mon
A Widely Used Syringe Has Been Recalled Nationwide by a Major Healthcare Company
The issue first came to light last September, when Cardinal Health, Inc. sent a letter to healthcare providers and consumers warning that their Monoject U-100 1 mL Insulin Syringe Luer-Lock with ...
The Pharma Letter2d
FDA nod for first rapid-acting insulin biosimilar
The US Food and Drug Administration has approved Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart), ...
Hosted on MSN2mon
8 common myths about insulin busted
Insulin pens with ultra-fine needles and pre-filled cartridges ensure minimal discomfort, while insulin pumps offer continuous delivery without frequent injections. With proper training ...
Medscape1y
Patient Satisfaction and Costs Associated With Insulin Administered by Pen Device or Syringe During Hospitalization
NovoFine Autocover 30G disposable safety needles were dispensed for patients enrolled in the pen group. If insulin glargine was prescribed, a vial was dispensed regardless of the treatment group ...